{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:11:45Z","timestamp":1792987905614,"version":"4.5.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Calcitriol-induced hypercalcemia is most frequently caused by granulomatous and inflammatory conditions such as sarcoidosis as well as lymphoma. Recently, pathogenic CYP24A1 variants resulting in inability of the 24-hydroxylase enzyme to deactivate 1,25(OH)2D has been found to be a cause of calcitriol-induced hypercalciuria and hypercalcemia in children and adults. Patients may present with hypercalcemia, suppressed PTH, hypercalciuria, and renal stones. We describe 4 young women and 1 man with calcitriol-associated hypercalcemia in whom pathogenic CYP24A1 variants were found to be the cause. In 2 of the 3 women who became pregnant, hypercalcemia worsened (the calcium was not checked during pregnancy in the third). Lactation was associated with worsened hypercalcemia in the 2 women who breast-fed. In the other woman who did not become pregnant, serum calcium levels varied from high normal to markedly elevated often without an explanation. The male patient was a middle-aged man with a long history of kidney stones and hypercalcemia as well as a family history of kidney stones. Gene sequencing confirmed that each patient had 2 variants in CYP24A1. We share 5 cases of a rare condition and further broaden the presentation of CYP24A1 variants to not only include worsening hypercalcemia in pregnancy, but also during lactation. Further calcium levels may vary markedly in patients with this condition. Physicians should consider pathogenic CYP24A1 variants in patients with unexplained calcitriol-associated hypercalcemia\/hypercalciuria.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziaf102","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T02:49:47Z","timestamp":1749782987000},"source":"Crossref","is-referenced-by-count":3,"title":["Hypercalcemia due to <i>CYP24A1<\/i> variants in five unrelated patients: diagnostic and clinical considerations"],"prefix":"10.1093","volume":"9","author":[{"given":"Jenna L","family":"Sarvaideo","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Molecular Medicine (Department of Medicine), Medical College of Wisconsin , Milwaukee, WI 53226,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M","family":"Col\u00f3n-Franco","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cleveland Clinic , Cleveland, OH 44195,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Kumar","sequence":"additional","affiliation":[{"name":"Division of Nephrology (Department of Medicine), Mayo Clinic , Rochester, MN 55905,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L","family":"Shaker","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Molecular Medicine (Department of Medicine), Medical College of Wisconsin , Milwaukee, WI 53226,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"issue":"5","key":"2025080403465115900_ref1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1210\/er.2016-1070","article-title":"Vitamin D-mediated hypercalcemia: mechanisms, diagnosis, and treatment","volume":"37","author":"Tebben","year":"2016","journal-title":"Endocr Rev"},{"issue":"5","key":"2025080403465115900_ref2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1056\/NEJMoa1103864","article-title":"Mutations in CYP24A1 and idiopathic infantile hypercalcemia","volume":"365","author":"Schlingmann","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"2025080403465115900_ref3","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1210\/jc.2013-3802","article-title":"A lifetime of hypercalcemia and hypercalciuria, finally explained","volume":"99","author":"Jacobs","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025080403465115900_ref4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/ckj\/sft008","article-title":"Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation","volume":"6","author":"Meusburger","year":"2013","journal-title":"Clin Kidney J"},{"issue":"2","key":"2025080403465115900_ref5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.juro.2013.02.3188","article-title":"Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis","volume":"190","author":"Dinour","year":"2013","journal-title":"J Urol"},{"issue":"8","key":"2025080403465115900_ref6","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1210\/jc.2015-1973","article-title":"Maternal hypercalcemia due to failure of 1,25-dihydroxyvitamin-D3 catabolism in a patient with CYP24A1 mutations","volume":"100","author":"Shah","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025080403465115900_ref7","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.3390\/nu14122518","article-title":"Hypercalcemia in pregnancy due to CYP24A1 mutations: case report and review of the literature","volume":"14","author":"Pilz","year":"2022","journal-title":"Nutrients"},{"issue":"10","key":"2025080403465115900_ref8","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1002\/jbmr.2859","article-title":"A young woman with recurrent gestational hypercalcemia and acute pancreatitis caused by CYP24A1 deficiency","volume":"31","author":"Woods","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2025080403465115900_ref9","doi-asserted-by":"publisher","first-page":"bvab119","DOI":"10.1210\/jendso\/bvab119","article-title":"24-hydroxylase deficiency due to CYP24A1 sequence variants: comparison with other vitamin D-mediated hypercalcemia disorders","volume":"5","author":"Azer","year":"2021","journal-title":"J Endocr Soc"},{"issue":"9","key":"2025080403465115900_ref10","doi-asserted-by":"publisher","first-page":"e10788","DOI":"10.1002\/jbm4.10788","article-title":"Hypervitaminosis D secondary to a CYP24A1 loss-of-function mutation: an unusual cause of hypercalcemia in two siblings","volume":"7","author":"Collins","year":"2023","journal-title":"JBMR Plus"},{"key":"2025080403465115900_ref11","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Whyte"},{"key":"2025080403465115900_ref12","volume-title":"Vitamin D: Production, Metabolism and Mechanisms of Action","author":"Bikle","year":"2000"},{"key":"2025080403465115900_ref13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jsbmb.2012.09.012","article-title":"Interplay between vitamin D and the drug metabolizing enzyme CYP3A4","volume":"136","author":"Wang","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"2025080403465115900_ref14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1681\/ASN.2014101025","article-title":"Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia","volume":"27","author":"Schlingmann","year":"2016","journal-title":"J Am Soc Nephrol JASN"},{"issue":"4","key":"2025080403465115900_ref15","doi-asserted-by":"publisher","first-page":"e278","DOI":"10.4158\/ACCR-2017-0041","article-title":"Blau syndrome: an unusual cause of hypercalcemia in a child","volume":"4","author":"Lo","year":"2018","journal-title":"AACE Clin Case Rep"},{"issue":"7","key":"2025080403465115900_ref16","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/jbmr.3135","article-title":"Improved screening test for idiopathic infantile hypercalcemia confirms residual levels of serum 24,25-(OH)2 D3 in affected patients","volume":"32","author":"Kaufmann","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2025080403465115900_ref17","doi-asserted-by":"publisher","first-page":"E1343","DOI":"10.1210\/jc.2014-4387","article-title":"CYP24A1 mutations in a cohort of Hypercalcemic patients: evidence for a recessive trait","volume":"100","author":"Molin","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2025080403465115900_ref18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/B978-0-323-91386-7.00024-6","volume-title":"Feldman and Pike\u2019s Vitamin D","author":"St-Arnaud","year":"2024","edition":"Fifth Edition"},{"issue":"10","key":"2025080403465115900_ref19","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1007\/s00198-016-3615-6","article-title":"Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect","volume":"27","author":"O\u2019Keeffe","year":"2016","journal-title":"Osteoporos Int"},{"issue":"3","key":"2025080403465115900_ref20","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1210\/clinem\/dgaa876","article-title":"Do the heterozygous carriers of a CYP24A1 mutation display a different biochemical phenotype than wild types?","volume":"106","author":"Brancatella","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025080403465115900_ref21","doi-asserted-by":"publisher","first-page":"E423","DOI":"10.1210\/jc.2011-1935","article-title":"Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy","volume":"97","author":"Tebben","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025080403465115900_ref22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/ckj\/sfv028","article-title":"Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole","volume":"8","author":"Sayers","year":"2015","journal-title":"Clin Kidney J"},{"issue":"4","key":"2025080403465115900_ref23","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/archinte.1989.00390040040007","article-title":"Adrenal crisis in the setting of high-dose ketoconazole therapy","volume":"149","author":"Khosla","year":"1989","journal-title":"Arch Intern Med"},{"issue":"12","key":"2025080403465115900_ref24","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1001\/archinte.1982.00340250097015","article-title":"Ketoconazole blocks testosterone synthesis","volume":"142","author":"Pont","year":"1982","journal-title":"Arch Intern Med"},{"issue":"5","key":"2025080403465115900_ref25","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jc.2016-4048","article-title":"CYP3A4 induction by rifampin: an alternative pathway for vitamin D inactivation in patients with CYP24A1 mutations","volume":"102","author":"Hawkes","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025080403465115900_ref26","doi-asserted-by":"publisher","first-page":"e3159","DOI":"10.1210\/clinem\/dgac315","article-title":"Long-term efficacy and safety of rifampin in the treatment of a patient carrying a CYP24A1 loss-of-function variant","volume":"107","author":"Brancatella","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2025080403465115900_ref27","author":"Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria (RICHH). (NCT03301038)"},{"key":"2025080403465115900_ref28","doi-asserted-by":"publisher","first-page":"106301","DOI":"10.1016\/j.jsbmb.2023.106301","article-title":"Rifampin monotherapy for children with idiopathic infantile hypercalcemia","volume":"231","author":"Lenherr-Taube","year":"2023","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"2025080403465115900_ref29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1056\/NEJMcpc2402485","article-title":"Case 21-2024: a 10-month-old boy with vomiting and hypercalcemia","volume":"391","author":"Jacobsen","year":"2024","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"2025080403465115900_ref30","doi-asserted-by":"publisher","first-page":"bvad114.553","DOI":"10.1210\/jendso\/bvad114.553","article-title":"SAT257 efficacy of oral cinacalcet in non-PTH non-malignant hypercalcemia from excess 1,25-dihydroxyvitamin D","volume":"7","author":"Mohan","year":"2023","journal-title":"J Endocr Soc"},{"issue":"2","key":"2025080403465115900_ref31","first-page":"160","article-title":"Intravenous pamidronate in the treatment of severe idiopathic infantile hypercalcemia","volume":"7","author":"Skalova","year":"2013","journal-title":"Iran J Kidney Dis"},{"issue":"4","key":"2025080403465115900_ref32","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1210\/jc.2013-1366","article-title":"Placental CYP27B1 and CYP24A1 expression in human placental tissue and their association with maternal and neonatal calcitropic hormones","volume":"99","author":"O\u2019Brien","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025080403465115900_ref33","doi-asserted-by":"publisher","first-page":"101062","DOI":"10.1016\/j.siny.2019.101062","article-title":"Calciotropic and phosphotropic hormones in fetal and neonatal bone development","volume":"25","author":"Ryan","year":"2020","journal-title":"Semin Fetal Neonatal Med"},{"issue":"2","key":"2025080403465115900_ref34","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/jpc.14219","article-title":"Rare cause of maternal and neonatal hypercalcaemia","volume":"55","author":"McBride","year":"2019","journal-title":"J Paediatr Child Health"},{"issue":"3","key":"2025080403465115900_ref35","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s12018-014-9157-6","article-title":"The role of PTHrP in regulating mineral metabolism during pregnancy, lactation, and Fetal\/neonatal development","volume":"12","author":"Kovacs","year":"2014","journal-title":"Clin Rev Bone Miner Metab"},{"issue":"8","key":"2025080403465115900_ref36","doi-asserted-by":"publisher","first-page":"ziae083","DOI":"10.1093\/jbmrpl\/ziae083","article-title":"Parathyroid hormone-related peptide induced hypercalcemia of pregnancy due to mammary hyperplasia","volume":"8","author":"Jodeh","year":"2024","journal-title":"JBMR Plus"},{"issue":"4","key":"2025080403465115900_ref37","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1210\/jc.2002-020773","article-title":"Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers","volume":"88","author":"Horwitz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025080403465115900_ref38","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1365-2265.1987.tb00824.x","article-title":"Remission of hypoparathyroidism during lactation: evidence for a physiological role for prolactin in the regulation of vitamin D metabolism","volume":"26","author":"Cundy","year":"1987","journal-title":"Clin Endocrinol"},{"issue":"1","key":"2025080403465115900_ref39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1053\/j.ajkd.2014.06.037","article-title":"Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations","volume":"65","author":"Figueres","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"2025080403465115900_ref40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1159\/000368520","article-title":"Discordant clinical course of vitamin-D-hydroxylase (CYP24A1) associated hypercalcemia in two adult brothers with nephrocalcinosis","volume":"40","author":"Jobst-Schwan","year":"2015","journal-title":"Kidney Blood Press Res"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziaf102\/63481339\/ziaf102.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/9\/9\/ziaf102\/63481339\/ziaf102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/9\/9\/ziaf102\/63481339\/ziaf102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T07:46:57Z","timestamp":1754293617000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziaf102\/8161301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziaf102","relation":{},"ISSN":["2473-4039"],"issn-type":[{"value":"2473-4039","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,6,13]]},"article-number":"ziaf102"}}